Found: 5
Select item for more details and to access through your institution.
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10649, doi. 10.3390/ijms221910649
- By:
- Publication type:
- Article
A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8542, doi. 10.3390/ijms21228542
- By:
- Publication type:
- Article
Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
- Published in:
- Journal of Neuroscience, 2017, v. 37, n. 6, p. 1413, doi. 10.1523/JNEUROSCI.2462-16.2016
- By:
- Publication type:
- Article
New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models.
- Published in:
- Brain Pathology, 2016, v. 26, n. 2, p. 237, doi. 10.1111/bpa.12351
- By:
- Publication type:
- Article
ALS mouse model SOD1<sup>G93A</sup> displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin.
- Published in:
- Human Molecular Genetics, 2016, v. 25, n. 8, p. 1588, doi. 10.1093/hmg/ddw035
- By:
- Publication type:
- Article